Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

10.48
Delayed Data
As of Jun 24
 -1.06 / -9.19%
Today’s Change
6.17
Today|||52-Week Range
22.66
-15.42%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close11.54
Today’s open10.81
Day’s range10.32 - 11.12
Volume523,032
Average volume (3 months)127,727
Market cap$339.6M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)-14.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.92

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.12+2.03%
PGNXProgenics Pharmaceut...-0.30-6.28%
CTMXCytomX Therapeutics ...+0.19+1.97%
ADMSAdamas Pharmaceutica...-0.72-4.43%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.82
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs